Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.
Saved in:
| Title: | Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer. |
|---|---|
| Authors: | Zhang, Shan1 (AUTHOR), Yao, Hong-Fei2 (AUTHOR), Li, Hui1 (AUTHOR), Su, Tong3 (AUTHOR), Jiang, Shu-Heng1 (AUTHOR), Wang, Hao4 (AUTHOR), Zhang, Zhi-Gang1 (AUTHOR) zzhang@shsci.org, Dong, Fang-Yuan5 (AUTHOR) dongfangyuan06@163.com, Yang, Qin6 (AUTHOR) yangqin200954@163.com, Yang, Xiao-Mei1 (AUTHOR) xmyang@shsci.org |
| Source: | Cellular Oncology (2211-3428). Oct2023, Vol. 46 Issue 5, p1473-1492. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
